Skip to main content
. 2019 Feb 12;10(4):769–774. doi: 10.1111/1759-7714.12996

Figure 4.

Figure 4

Survival curves following recurrence in patients administered chemotherapy as second‐line treatment according to the presurgical treatment type, classified on the basis of the mean time to recurrence from the day after surgery (262 days): (a) no presurgical treatment (P = 0.850), (b) neoadjuvant chemotherapy (NAC) (P = 0.336). (Inline graphic) Late recurrence, and (Inline graphic) Early recurrence. OS, overall survival.